Cannabinoid lists

410 ILCS 707/15, under Illinois Hemp Act.

410 ILCS 707/15

(410 ILCS 707/15)     (This Section may contain text from a Public Act with a delayed effective date)

    Sec. 15. Cannabinoid lists.     (a) The following lists shall be used to determine what is hemp and what products qualify as a final consumer hemp cannabinoid product under this Act:         (1) Cannabinoids that are considered capable of being     naturally produced by a Cannabis sativa L. plant:            (A) Cannabigerol (CBG), which includes, but is         not limited to:                (i) CBGA (Cannabigerolic acid);                 (ii) CBG (Cannabigerol);                 (iii) CBGVA (Cannabigerovarinic acid);                 (iv) CBGV (Cannabigerovarin);             (B) Cannabidiol (CBD), which includes, but is not         limited to:                (i) CBDA (Cannabidiolic acid);                 (ii) CBD (Cannabidiol);                 (iii) CBDVA (Cannabidivarinic acid);                 (iv) CBDV (Cannabidivarin);             (C) Delta 9-Tetrahydrocannabinol (THC), which         includes, but is not limited to:                (i) THCA (Delta 9-Tetrahydrocannabinolic             acid);                (ii) Delta 9-THC (Delta             9-Tetrahydrocannabinol);                (iii) THCVA (Tetrahydrocannabivarinic acid);                 (iv) THCV (Tetrahydrocannabivarin);                 (v) THCP (Tetrahydrocannabiphorol);             (D) Cannabichromene (CBC), which includes, but is         not limited to:                (i) CBCA (Cannabichromenic acid);                 (ii) CBC (Cannabichromene);                 (iii) CBCVA (Cannabichromevarinic acid);                 (iv) CBCV (Cannabichromevarin);             (E) Natural degradation and artifact subclasses,         which include, but are not limited to:                (i) CBN (Cannabinol);                 (ii) CBNA (Cannabinolic acid);                 (iii) CBLA (Cannabicyclolic acid);                 (iv) CBL (Cannabicyclol);                 (v) CBE (Cannabielsoin);                 (vi) CBT (Cannabitriol);                 (vii) HHC (Hexahydrocannabinol);             (F) Minor natural isomers and trace compounds,         which include, but are not limited to:                (i) Delta-8 THC (Delta             8-Tetrahydrocannabinol);                (ii) Delta-10 THC (Delta             10-Tetrahydrocannabinol);                (iii) exo-THC (Delta             9,11-Tetrahydrocannabinol);                (iv) THCA (Tetrahydrocannabinolic acid);                 (v) THC-C1 (Tetrahydrocannabiorcol); and             (G) All cannabinoids that appear on a list of         cannabinoids that are known to the federal Food and Drug Administration to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature, and that is published by the federal Food and Drug Administration pursuant to 7 U.S.C. 1639o.        (2) Cannabinoids that are tetrahydrocannabinol class     cannabinoids known to be naturally occurring in the Cannabis sativa L. plant:            (A) THCA (Delta 9-Tetrahydrocannabinolic acid);             (B) THC (Delta 9-Tetrahydrocannabinol);             (C) THCV (Tetrahydrocannabivarin);             (D) THCVA (Tetrahydrocannabivarin acid);             (E) THCP (Tetrahydrocannabiphorol); and             (F) All tetrahydrocannabinol class cannabinoids         that appear on a list of tetrahydrocannabinol class cannabinoids that are known to the federal Food and Drug Administration to be naturally occurring in the Cannabis sativa L. plant and that are published by the federal Food and Drug Administration pursuant to 7 U.S.C. 1639o.        (3) Cannabinoids that are known to have similar     effects to, or marketed to have similar effects to, tetrahydrocannabinol class cannabinoids:            (A) Delta-5 THC (Delta-5 tetrahydrocannabinol);             (B) Delta-6 THC (Delta-6 tetrahydrocannabinol);             (C) Delta-7 THC (Delta 7-Tetrahydrocannabinol);             (D) Delta-8 THC (Delta 8-Tetrahydrocannabinol);             (E) Delta-10 THC (Delta 10-Tetrahydrocannabinol);             (F) Delta-6a10a THC (often sold as Delta-3 THC);             (G) Delta 10a THC (Delta 10-Tetrahydrocannabinol         acid);            (H) Delta-11 THC (Delta-11tetrahydrocannabinol)             (I) HHC (Hexahydrocannabinol);             (J) HHCP (Hexahydrocannabiphorol);             (K) HHCH (Hexahydrocannabihexol);             (L) exo-THC (Delta 9,11-Tetrahydrocannabinol);             (M) THCP (Tetrahydrocannabiphorol);             (N) THCB (Tetrahydrocannabutol);             (O) THCH (Tetrahydrocannabihexol);             (P) THC-O-Acetate (Delta-9-Tetrahydrocannabinol         acetate, THC-O/ATHC);            (Q) HHC-O-Acetate (Hexahydrocannabinol O acetate,         HHC-O);            (R) THCP-O         (Delta-9-Tetrahydrocannabiphorol-O-acetate);             (S) THCJD (Tetrahydrocannabioctyl); and             (T) All tetrahydrocannabinol class cannabinoids         that appear on a list of cannabinoids that are known to the federal Food and Drug Administration to have similar effects to, or marketed to have similar effects to, tetrahydrocannabinol class cannabinoids and that is published by the federal Food and Drug Administration pursuant to 7 U.S.C. 1639o.    (b) The Department, by rule, may add, change, or remove any of the items included in the lists established in this Section.     (c) The Department shall publish any updates to the list, including any federal additions, on its website.

(Source: P.A. 104-463, eff. 11-12-26.)